Company intelligence / Profile preview

January AI

Menlo Park, California, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

January AI has published data from clinical programs including ADA 2020 presentations highlighting the ability of its platform to predict glucose response and deliver behavioral interventions for metabolic health; the solution is commercially deployed and evidenced by peer-reviewed science focusing on digital health outcomes[2][6].

Therapeutic areas: OtherEndocrinologyMetabolic Disorders
Modalities: DeviceNon-pharmacological therapyDigital healthWearable-enabled analytics
Industry: Digital Health Medical Devices

Partnerships

Mars Advanced Research Institute (MARI)Nestle

Beyond the preview

Go deeper on January AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on January AI.

Explore the full profile